Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aecom (ACM) vs Boston Scientific Corporation (BSX) Price & Performance

Boston Scientific CorporationTrade

Price performance (Past 24H)

Key statistics

Aecom vs Boston Scientific Corporation — how do they compare? Aecom trades at $62.95 (market cap $8.62B), while Boston Scientific Corporation trades at $50.74 (market cap $74.19B). The key difference: Boston Scientific Corporation is far larger — about 8.6× Aecom's market cap, and Aecom pays a 1.77% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.

ACMBSX
Market Cap
$8.62B$74.19B
Sector
IndustrialsHealth
52-Week High
$134.35$108.14
52-Week Low
$66.86$42.63
Enterprise Value
$10.81B$86.27B
Dividend Yield
1.77%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Aecom

ACM's stock is trading at $73.30, down 3.35% in the last session, reflecting negative momentum after a Q2 2026 earnings miss. The technical outlook is bearish, with support at $72 and resistance at $76. Fundamentally, revenue reached $16.14 billion in 2025, but net income margin is thin at 1.87%, and ROE is negative. Recent news includes a securities investigation announcement and a large project charge impacting earnings.

The investment outlook is mixed: analyst consensus is bullish with a $88.25 price target, but risks include earnings volatility, a fraud probe, and rising debt-to-asset ratio. Opportunities lie in record backlog growth and new project wins like the Lisbon airport design. Investors should weigh strong institutional support against operational and legal headwinds.

Boston Scientific Corporation

BSX trades at $50.46, up 2.33% today, with strong earnings beats in recent quarters and a bullish technical trend. Revenue grew to $20.07B in 2025, with net income margin expanding to 17.5%. The stock shows robust institutional support and insider buying, while facing near-term headwinds from competitive pressures in key segments like WATCHMAN.

Outlook remains positive with 86% analyst buy ratings and a $67.21 consensus price target, implying 33% upside. Risks include guidance cuts and market share losses, but solid cash flow and valuation metrics support long-term growth potential for patient investors.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Aecom

Aecom is one of the largest global providers of design, engineering, construction, and management services. The firm serves a broad spectrum of end markets including infrastructure, water, transportation, and energy. Based in Los Angeles, Aecom has a presence in over 150 countries and employs 51,000. The company generated $13.3 billion in sales and $701 million in adjusted operating income in fiscal 2021.

Read more on ACM

About Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Read more on BSX